SELLAS Life Sciences Group, Inc. (SLS)

5.96 +0.43 (+7.78%) USD  |  NASDAQ  |  Mar 09, 16:00
5.96 0.00 (0.00%) After-Hours: 16:12
More

SELLAS Life Sciences Group Net Common Equity Issued (Purchased) (Annual)

Net Common Equity Issued (Purchased) (Annual) Chart

View Net Common Equity Issued (Purchased) (Annual) for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Common Equity Issued (Purchased) (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years

View Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Common Equity Issued (Purchased) (Annual) Benchmarks

View Net Common Equity Issued (Purchased) (Annual) Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade
GT Biopharma, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Lyell Immunopharma, Inc. Upgrade